Trial Profile
A observational, retrospective study evaluating effectiveness of Vortioxetine treatment on sleep quality, daytime sleepiness and depressive symptoms in patients with major depressive disorder affected with insomnia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Oct 2018
Price :
$35
*
At a glance
- Drugs Vortioxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 24 Oct 2018 New trial record
- 16 Oct 2018 Results published in the British Journal of Clinical Pharmacology